[Ataractic treatment in psychiatry and general medicine. Review of preparations. 9].
D000275:Adjustment Disorders / Q000188:drug therapy; D000873:Anthracenes / Q000627:therapeutic use; D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; D006801:Humans; D008140:Lorazepam / Q000031:analogs & derivatives / Q000627:therapeutic use; D008376:Maprotiline / Q000627:therapeutic use; D008472:Medazepam / Q000627:therapeutic use; D009497:Neurotic Disorders / Q000188:drug therapy*; D011602:Psychophysiologic Disorders / Q000188:drug therapy; D011618:Psychotic Disorders / Q000188:drug therapy*; D012893:Sleep Wake Disorders / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D000873:Anthracenes; D014151:Anti-Anxiety Agents; D014149:Tranquilizing Agents; D001569:Benzodiazepines; D008376:Maprotiline; C005100:melitracene; C023842:lormetazepam; D008140:Lorazepam; D008472:Medazepam
Die ataraktische Behandlung in Psychiatrie und Allgemeinmedizin. Präparate-Ubersicht, Folge 9.